| Date
|
Content
|
| 12/27/2022
|
Weekly Broadcast
|
| 12/19/2022
|
Weekly Broadcast
|
| 12/12/2022
|
Weekly Broadcast
|
| 12/8/2022
|
NRG-GY018 Patients Entered to Step 1 Can Proceed to Step 2
|
| 12/5/2022
|
Weekly Broadcast
|
| 12/2/2022
|
NRG-BR005 Permanent Study Closure
|
| 12/2/2022
|
NRG-BN010 Temporarily Closed to Accrual
|
| 11/30/2022
|
NRG-GY018 Anticipated Closure to Accrual
|
| 11/28/2022
|
Weekly Broadcast
|
| 11/21/2022
|
Weekly Broadcast
|
| 11/14/2022
|
Weekly Broadcast
|
| 11/7/2022
|
Weekly Broadcast
|
| 10/31/2022
|
Weekly Broadcast
|
| 10/24/2022
|
Weekly Broadcast
|
| 10/17/2022
|
Weekly Broadcast
|
| 10/10/2022
|
Weekly Broadcast: NRG-GY005, NRG-GY022, NRG-GI008, GOG-0210, GOG-0238, GOG-0258, GOG-0263, NRG-GY006
|
| 10/3/2022
|
Weekly Broadcast: NRG-HN010, NRG-GY022, NSABP B-55/BIG 6-13, NRG-GU011, NRG-GY006, GOG 0210
|
| 9/26/2022
|
Weekly Broadcast: NRG-BN010, NRG-GU007, NRG-GY006, NRG-BR004, NRG-LU005, NRG-GY022, NRG-BN012, NRG-GI008, NRG-GU012, NRG-GY003, NRG-GY003, GOG-0210
|
| 9/26/2022
|
NRG-BN010 Reopen to Safety Run-In/Dose Level 2
|
| 9/26/2022
|
NRG-GU007 Reopen to Dose Level 3
|
| 9/19/2022
|
Weekly Broadcast: NRG-CC010, NRG-GY022, NRG-GY014, NRG-GI003, NRG-GY023, NRG-GY006, GOG-0210
|
| 9/12/2022
|
Weekly Broadcast: NRG-DT001, NRG-GY022, NRG-GU012, NRG-GY006, GOG-0210, NRG-LU002
|
| 9/6/2022
|
Weekly Broadcast: NRG-BN012, NRG-GU002, NRG-GY020, NRG-HN004, NRG-DT001, NRG-GY022, NRG-CC005/FORTE, NRG-GI005, NRG-GI008, NRG-GY006, GOG-0210
|
| 8/31/2022
|
NRG-BN012 Protocol Activation
|
| 8/31/2022
|
NRG-DT001 Cohort B Closure Notice
|
| 8/29/2022
|
Weekly Broadcast: NRG-GY022, NRG-BR007, GOG-0210, NRG-GY006, NRG-GY018, NRG-GY020, NRG-HN006
|
| 8/22/2022
|
Weekly Broadcast: NRG-GU002, NRG-GY018, NRG-GY022, NRG-BR007, NRG-GI005, NRG-GU012, NRG-GY006, NRG-GY020, GOG-0210
|
| 8/15/2022
|
Weekly Broadcast
|
| 8/11/2022
|
NRG-HN001: QOL Study: FACT-NP and EQ-5D for newly enrolled patients
|
| 8/8/2022
|
Weekly Broadcast: NRG-GY022, NRG-GI008, NRG-GI005, NRG-GY018
|
| 8/1/2022
|
Weekly Broadcast: NRG-GY022, NRG-CC007CD, NRG-CC009, NRG-BN003, NRG-GI005, NRG-GU010, NRG-GU012, GOG-0210, NRG-GY019
|
| 7/25/2022
|
Weekly Broadcast: NRG-CC003, RTOG 1112, NRG-GU009, NRG-GU010, NRG-LU006
|
| 7/18/2022
|
Weekly Broadcast
|
| 7/11/2022
|
Weekly Broadcast: NRG-CC005, NRG-GY027, NRG-LU006
|
| 7/11/2022
|
NRG-GU007: Temporary Closure
|
| 7/5/2022
|
Weekly Broadcast: NRG-GU012, NRG-GY029, NRG-BN010, NRG-CC005, NRG-GI005, NRG-GU007, GOG-0210, GOG-0212, GOG-0259, GOG-0264, GOG-0267, GOG-0268, GOG-0279, GOG-0283, NRG-CC008, NRG-LU006
|
| 6/29/2022
|
NRG-BN010: Temporary Closure
|
| 6/27/2022
|
Weekly Broadcast: NRG-GY027, NRG-LU005, NRG-BN003, NRG-CC005
|
| 6/21/2022
|
Weekly Broadcast: NRG-GI008, NRG-CC003, NRG-GY014, NRG-BR004, NRG-CC005, RTOG 1112, GOG-0210
|
| 6/17/2022
|
NRG-CC003: Closure
|
| 6/16/2022
|
NRG-GI008 Reopened to Accrual
|
| 6/15/2022
|
RTOG 1112 Call for submission of data
|
| 6/13/2022
|
Weekly Broadcast: RTOG 1112, NRG-GY012, NRG-HN008, NRG-GU005, NRG-CC005, GOG-0210, NRG-GY014
|
| 6/6/2022
|
Weekly Broadcast: NRG-CC005, NRG-CC009, NRG-GY018, NRG-BR002, NRG-GI008, NRG-GU005, NRG-BR004, GOG-0210, NRG-GY014
|
| 6/6/2022
|
NRG-GU005: Closure Notice
|
| 6/3/2022
|
NRG-GI008: Temporary Accrual Hold
|
| 6/3/2022
|
FORTE Study: NRG-CC005 Amendment 4 Activation
|
| 5/31/2022
|
Weekly Broadcast: NRG-GY022, NRG-CC005, NRG-GU007, GOG-0210, NRG-GY014
|
| 5/24/2022
|
NRG-GY022: Temporary Closure on June 1, 2022
|
| 5/23/2022
|
Weekly Broadcast: NRG-GY012, NRG-BR004, GOG-0261, NRG-GY014, NRG-GY024, NRG-LU006
|
| 5/20/2022
|
NRG-BR004 Study Closure
|
| 5/20/2022
|
NRG Oncology Study Terminations
|
| 5/16/2022
|
Weekly Broadcast: NRG-BN001, NRG-GY022, NRG-BR003, NRG-BR004, NRG-BR007, NRG-GI004, NRG-GI005, NRG-GI008, NRG-CC005, GOG-0210, NRG-GY014, RTOG 1216, NRG-LU006
|
| 5/2/2022
|
Weekly Broadcast: NRG-BN004, NRG-BR004, NRG-GY014, NRG-GU005
|
| 4/29/2022
|
NRG-BR004 Temporary Closure
|
|
|